- Plant expansion increases capacity for the manufacture of molding compounds made of poly(methyl methacrylate) (PMMA) to 40,000 metric tons
- Evonik strengthens its market position as one of the world’s leading suppliers of specialty polymers
- The move also acknowledges growing demand for PMMA molding compounds in other regions
The last quarter of 2011 has seen phase-two expansion of Evonik’s PMMA plant in Shanghai completed and put online, thereby doubling its regional manufacturing capacity for molding compounds made of poly(methyl methacrylate) (PMMA) to around 40,000 metric tons.
The PMMA facility, part of a world-scale methacrylate complex, originally commenced with production of PLEXIGLAS® molding compounds for the Chinese and all other Asian markets back in 2008.
Evonik began investing in the region as an early mover when it set up its methacrylate complex—a project entailing total expenditure of more than 200 million euro. The expansion of capacity at the plant acknowledges the continued, undiminished, growth of the market and represents a further step forward for the corporation within the scope of its long-term Asia strategy. "This move sees us further strengthening our position as one of the world’s biggest suppliers of specialty polymers and also lending additional import to our Shanghai operations," says Gregor Hetzke, the head of Evonik’s Performance Polymers Business Unit.
Evonik’s PMMA molding compounds enjoy international renown under the popular PLEXIGLAS® brand name. It supplies its extensive product range of PLEXIGLAS® molding compounds to a variety of industries, among them automotive and electronics manufactures and the lighting industry.
This latest expansion of the PMMA plant also makes accommodations for growing demand in Europe as it helps to better secure supply availability of PLEXIGLAS® molding compounds for customers outside of Asia.
Evonik Industries is a worldwide manufacturer of PMMA products sold under the
PLEXIGLAS® trademark on the European, Asian, African and Australian continents
and under the trademark ACRYLITE® in the Americas.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.